discovered by Ockner et al. in 1972 ( 2 ) and was originally named Z-protein. Since that time, there has been an explosive growth in information regarding the role of L-FABP in cellular homeostasis. While FABPs are present in many tissues, such as heart, brain, intestinal, skin, adipose, muscle, epidermal, ileal, myelin, and testis, L-FABP is found in abundance in hepatocytes where it accounts for ف 2% of the total cellular protein. Although L-FABP is abundant in the liver, it also is present in tissues such as murine alveolar macrophages ( 3 ), kidney ( 4 ), and intestine ( 5 ).L-FABP is made up of 127 amino acids that compose 10 antiparallel  -strands. These stands are organized into two fi ve-stranded  -sheets and two ␣ -helices. The two ␣ -helices are hypothesized to function as a portal that controls entry and release of ligands from the binding pocket created by the  -strands ( 6 ). A large interior water-fi lled cavity forms the confi nes of the  -strands, which serve as the hydrophobic ligand-binding site. L-FABP is able to bind and translocate many lipophilic substrates throughout the cytosol. Some of these substrates include long-chain fatty acids ( 7-9 ), bile acids ( 10 ), eicosanoids ( 11 ), and hypolipidemic drugs ( 12 ). Transfer of these ligands from L-FABP to membranes is thought to occur by a diffusive process; i.e., the ligand fi rst dissociates from the binding pocket and then diffuses to its site of action, while transfer of ligands from other FABPs, such as I-FABP, is thought to occur by a direct collisional interaction ( 13 ). It seems that L-FABP also plays a role in transferring bound ligands into the nucleus. These ligands could activate the peroxisome proliferator-activated receptor ␣ nuclear receptors and